Cite
HARVARD Citation
Falcone, A. et al. (n.d.). 2150 Low rates of hospitalizations with TAS-102 in the European (EU) subregion of the Phase 3 RECOURSE trial in patients (pts) with metastatic colorectal cancer (mCRC). European journal of cancer. pp. S383-. [Online].